Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial ophthalmic artery melphalan for intraocular retinoblastoma
2008-005583-14Phase 2Terminated
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melphalan in retinoblastoma (Rb), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Avoidance of enucleation. Started Sep 2008; status: terminated.
02
Drugs
melphalan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on 2008-005583-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005583-14.